Varda Space is launching a commercial mission to manufacture pharmaceutical compounds in microgravity, marking one of the first deals to develop medicine molecules in orbit and return them to Earth.
The partnership between Varda Space and United Therapeutics represents an early-stage effort to leverage the unique conditions of low Earth orbit for drug development. Microgravity environments enable the creation of drug molecules with properties difficult or impossible to achieve on the ground, potentially improving therapeutic effectiveness.
Varda CEO Will Bruey has signaled confidence in the commercial viability of orbital pharmaceutical manufacturing, suggesting additional missions may follow. The company plans to send medicines into space and retrieve them for further analysis and development.
While still in early phases, the deal signals growing interest from pharmaceutical companies in space-based research. Several firms have explored microgravity applications for protein crystals and drug formulations. Success could open a new market segment for commercial space ventures seeking revenue beyond satellite deployment and tourism.
The missions will test whether orbital manufacturing can deliver measurable advantages in drug efficacy, manufacturing efficiency, or cost—key factors determining whether space-based pharma production becomes economically viable at scale.
Amsterdam-based Monumental secured a $32 million Series B round led by Khosla Ventures. The company develops autonomous robotics and AI software for the construction industry.
Indian AI coding startup Emergent reached a $1.5 billion valuation in its latest funding round, raising $130 million in Series C and joining the unicorn club after a five-fold valuation jump in six months.
Rime, an AI platform processing over 100 million calls monthly, secured $24 million in Series A funding to expand its customer service solutions for enterprises.
A former SpaceX engineer has secured $65 million in funding to revolutionize wire harness manufacturing for aerospace and defense. The startup aims to replace decades-old production methods still used in rockets, missiles, and satellites.